Ammar Mektebi

ORCID: 0000-0001-5022-3681
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Anesthesia and Pain Management
  • Spine and Intervertebral Disc Pathology
  • Cardiac, Anesthesia and Surgical Outcomes
  • Dietary Effects on Health
  • Diabetes Treatment and Management
  • Optimism, Hope, and Well-being
  • Schizophrenia research and treatment
  • Artificial Intelligence in Healthcare and Education
  • History of Medical Practice
  • Congenital Diaphragmatic Hernia Studies
  • Respiratory Support and Mechanisms
  • Poxvirus research and outbreaks
  • Bipolar Disorder and Treatment
  • Neonatal Respiratory Health Research
  • Herpesvirus Infections and Treatments
  • Bacillus and Francisella bacterial research
  • Circadian rhythm and melatonin
  • Global Health and Surgery

Kutahya Saglik Bilimleri Universitesi
2023-2025

Universidad CES
2023-2025

Sağlık Bilimleri Üniversitesi
2023

Scientific Research Group in Egypt
2023

Introduction: This study explores the impact of observing Ramadan intermittent fasting (RIF) on body weight in Turkish residents, marking it as first conducted Turkey to investigate interplay religious with dietary changes amid COVID‐19 pandemic. We hypothesized that would result loss attributable changes, while decreased physical activity correlate gain during this period. Methods: A cross‐sectional survey was among Muslims aged 18+ who fasted at least two days 2021. Data were collected via...

10.1155/jnme/8851660 article EN cc-by Journal of Nutrition and Metabolism 2025-01-01

Of around 2 billion Muslims worldwide, approximately 1.5 observe Ramadan fasting (RF) month. Those that RF have diverse cultural, ethnic, social, and economic backgrounds are distributed over a wide geographical area. Sleep is known to be significantly altered during the month of Ramadan, which has profound impact on human health. Moreover, sleep closely connected dietary lifestyle behaviors.This cross-sectional study collected data using structured, self-administered electronic...

10.3389/fnut.2023.1040355 article EN cc-by Frontiers in Nutrition 2023-03-08

Abstract Background and Hypothesis Schizophrenic patients are at a higher risk of developing prediabetes obesity, which may increase their cardiovascular other diseases. Liraglutide, glucagon-like peptide-1 receptor agonist, is effective in treating obesity the general population. However, its efficacy safety schizophrenic remain unclear. This study aims to evaluate effectiveness liraglutide managing among patients. Study Design A systematic PRISMA-based literature search was conducted three...

10.21203/rs.3.rs-3150409/v1 preprint EN cc-by Research Square (Research Square) 2023-08-02
Coming Soon ...